Una sesión concisa y dirigida por expertos sobre la hipertensión pulmonar del Grupo 2—diagnóstico, clasificación actualizada y estrategias de tratamiento—con un análisis de caso en vivo.
A concise, expert-led session in Spanish exploring Group 2 pulmonary hypertension—its diagnosis, updated classification, and treatment strategies—featuring a live case discussion.
Leading researchers showcase cutting-edge bioengineering and bioprinting technologies — from organ-on-a-chip models to 3D-printed vasculature — driving new insights into pulmonary hypertension mechanisms and therapies.
Join us 28 January – 1 February as we celebrate 20 years of progress and innovation in PH. This year’s programme highlights advances in PAH, CTEPH, and PH in lung disease, with sessions on emerging therapies, precision medicine, and future directions.
Join us for two optional fundraising activities at PVRI 2026 Dublin as we celebrate 20 years of global collaboration. Take part in our morning run/walk or relaxed pub social and help support PVRI’s mission to advance PH awareness, research, and care worldwide.
Living Legend Stuart Rich shares insights from four decades of pioneering research that transformed the understanding and treatment of pulmonary hypertension, in conversation with Serpil Erzurum and Saad Kubba.
Leading experts explore how exercise physiology, metabolism, and the microbiome are reshaping our understanding of body composition and its role in pulmonary hypertension.
Living Legend Paul Corris reflects on a career that shaped global lung transplantation and pulmonary hypertension care, sharing his insights and experiences with Patricia Thistlethwaite and Nolan Winicki.
